CompoAtlas

Pink Lotus Alternative Care

Natural health product licensed in Canada

Licence holder
Pink Lotus Alternative Care
NPN or DIN-HM
80080146
Status
Active licence
Licence date
20 September 2017
Revision date
Not provided
Form
Crème
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Santalum album

Source : Bois

0.03 Pour cent
Lavandula angustifolia

Source : Sommité en fleurs (herbe)

0.065 Pour cent
Cedrus atlantica

Source : Bois

1.63 Pour cent
Pogostemon cablin

Source : Feuille

0.065 Pour cent
Boswellia frereana

Source : Stem resin

0.049 Pour cent

Non-medicinal ingredients

Huile de graine de Cannabis Sativa, Beurre de graine de Mangifera Indica (Mangue), Huile essentielle du baume de Copaifera Reticulata, Beurre de graines de Theobroma cacao (Cacao), Amidon de maïs

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Crème1 Tous les jours

Uses authorised in Canada

Used in aromatherapy to help relieve joint/muslce pain associated with sprain/strain/rheumatoid arthritis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80080146

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line